These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33847928)

  • 1. Quantification of Complement Proteins with Special Reference to C1q: Multiplex Versus ELISA Versus Rocket Immunoelectrophoresis Versus Nephelometry.
    Sandholm K; Persson B; Abdalla S; Mohlin C; Nilsson B; Ekdahl KN
    Methods Mol Biol; 2021; 2227():33-41. PubMed ID: 33847928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic Use.
    Sandholm K; Persson B; Skattum L; Eggertsen G; Nyman D; Gunnarsson I; Svenungson E; Nilsson B; Ekdahl KN
    Front Immunol; 2019; 10():7. PubMed ID: 30740097
    [No Abstract]   [Full Text] [Related]  

  • 3. Report of an IUIS/WHO working group. Use and abuse laboratory tests in clinical immunology: critical considerations of eight widely-used diagnostic procedures. 18.-20. May 1981 in Geneva.
    Allerg Immunol (Leipz); 1982; 28(1):21-35. PubMed ID: 6214170
    [No Abstract]   [Full Text] [Related]  

  • 4. Development and validation of an automated particle-enhanced nephelometric immunoassay method for the measurement of human plasma C1q.
    Borque L; Olivan V; Iguaz F
    J Clin Lab Anal; 1995; 9(5):302-7. PubMed ID: 8531011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel ELISA for the evaluation of the classical pathway of complement.
    Zwirner J; Wittig A; Kremmer E; Götze O
    J Immunol Methods; 1998 Feb; 211(1-2):183-90. PubMed ID: 9617842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination in the nanogram range of C1q in serum and unconcentrated CSF by electro-immunodiffusion.
    Schuller E; Helary M
    J Immunol Methods; 1983 Jan; 56(2):159-65. PubMed ID: 6600765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-C1q Autoantibodies: Standard Quantification and Innovative ELISA.
    Csorba K; Schirmbeck L; Dubler D; Trendelenburg M
    Methods Mol Biol; 2021; 2227():107-114. PubMed ID: 33847935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of C1q assay].
    Sasaki T; Yonemasu K
    Nihon Rinsho; 1990 Feb; 48 Suppl():637-40. PubMed ID: 2113134
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantification of C3d in biological fluids by an enzyme-linked immunosorbent assay.
    Peakman M; Lobo-Yeo A; Senaldi G; Nilsson M; Tee DE; Vergani D
    J Immunol Methods; 1987 Nov; 104(1-2):51-6. PubMed ID: 3500236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of complement-dependent prevention of immune precipitation in systemic sclerosis.
    Arason GJ; Geirsson AJ; Kolka R; Víkingsdóttir T; Valdimarsson H
    Ann Rheum Dis; 2002 Mar; 61(3):257-60. PubMed ID: 11830434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment and optimization of detection of the hepatitis B immune complexes].
    Xu LF; Wang J; Xu J; Shi N; Wu G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):291-3. PubMed ID: 17971950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy-specific beta 1-glycoprotein (SP1) determined by means of electroimmunoassay, radial immunodiffusion and nephelometry.
    Schultz-Larsen P; Lyngbye J; Westergaard JG; Teisner B
    Clin Chim Acta; 1979 Nov; 99(1):59-69. PubMed ID: 315285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of complement proteins C1q and C4bp to serum amyloid P component (SAP) in solid contra liquid phase.
    Sørensen IJ; Nielsen EH; Andersen O; Danielsen B; Svehag SE
    Scand J Immunol; 1996 Oct; 44(4):401-7. PubMed ID: 8845035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C1q-bearing immune complexes detected by a monoclonal antibody to human C1q in rheumatoid arthritis sera and synovial fluids.
    Antes U; Heinz HP; Schultz D; Brackertz D; Loos M
    Rheumatol Int; 1991; 10(6):245-50. PubMed ID: 2041983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of assays detecting complement activation. Complement-split product C3d (rocket immuno-electrophoresis) and C3d neodeterminants (ELISA).
    Espersen GT; Langeland B; Grunnet N
    Scand J Clin Lab Invest; 1990 Jun; 50(4):389-93. PubMed ID: 1697427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [C1 (q, r, s)].
    Yoshida H
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():57-9. PubMed ID: 20942001
    [No Abstract]   [Full Text] [Related]  

  • 17. An ELISA technique for the measurement of C1q in cerebrospinal fluid.
    Delamarche C; Berger F; Pouplard A; Emile J
    J Immunol Methods; 1988 Nov; 114(1-2):101-6. PubMed ID: 3141513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated turbidimetry of rheumatoid factor without heat inactivation of serum.
    Borque L; Rus A; Ruiz R
    Eur J Clin Chem Clin Biochem; 1991 Aug; 29(8):521-7. PubMed ID: 1954306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use and abuse of laboratory tests in clinical immunology: critical considerations of eight widely used diagnostic procedures. Report of a joint IUIS/WHO meeting on assessment of tests used in clinical immunology.
    Clin Immunol Immunopathol; 1982 Jul; 24(1):122-38. PubMed ID: 6809380
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis.
    Jaskowski TD; Litwin CM; Hill HR
    Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.